HUMAN PAPILLOMA VIRUS INFECTION AND GENITAL WARTS

That this House notes that diagnoses of genital warts in young people have continued to rise, with 66 per cent. of all new genital warts diagnoses in women being in those under 25; supports the call by FPA, Brook, Terrence Higgins Trust, the Royal Society for Public Health, Medical Foundation for AIDS and Sexual Health and the British Association for Sexual Health and HIV for the introduction of a quadrivalent Human Papilloma Virus (HPV) vaccine which protects against cervical cancer and against genital warts and will contribute to improving public health; urges the Government to reduce the current inequalities which exist to ensure that it is not only those who have the knowledge and financial resources who are able to assess the quadrivalent HPV vaccine and benefit from the protection it offers; and further urges the Government to take the opportunity to prevent both cervical cancer and genital warts.